OECD TG 402
OECD TG 402 is the standard ‘Acute Dermal Toxicity’, i.e. Acute dermal toxicity, which is in Section 4 (Health effects) included in the OECD Test Guidelines for the Testing of Chemicals. It was first adopted in 1987 and updated in 2017. The test is a in vivo-Toxicity test to assess the acute toxic effects of a substance following a single application to the skin.
The main objective of the test is to determine the systemic toxic effects that occur following the absorption of the test substance through the skin, as well as the LD50 value and the GHS/CLP classification. In addition, local effects (erythema, oedema, etc.) may be observed at the application site; however, the assessment of local irritation and corrosive effects is covered by separate standards (TG 404, TG 430, TG 431).
The basic principle of the test is as follows:
- The test substance is usually applied as a single dose to a depilated, healthy area of skin on rats or rabbits.
- The application site is usually kept covered with a closed or semi-closed dressing for 24 hours; any excess substance is then removed.
- The site of application is selected on the basis of the substance’s physico-chemical properties and the expected exposure.
- The animals are kept under clinical observation for at least 14 days; during this period, signs of toxicity, reversibility, changes in body weight and mortality are recorded.
- At the end of the study, a post-mortem examination is carried out and the macroscopic findings are documented.
- The doses are determined on the basis of preliminary tests (range-finding) or existing toxicity data; as a rule, several dose groups and a control group are used.
The main parameters reported in the study are:
- The doses administered (mg/kg body weight) and the administration conditions (duration, type of cover, area)
- Clinical observations and their onset
- Changes in body weight
- Mortality and survival times
- Local findings at the application site (erythema, oedema, necrosis, etc.)
- Post-mortem findings
- LD50 value and confidence interval
- GHS/CLP category for acute dermal toxicity and justification for the classification
- Animal species used, sex, age, method of administration and conditions of use
- Data on measurement uncertainty and repeatability
Why is it carried out?
The OECD TG 402 is being carried out for the following scientific and regulatory purposes:
- Assessment of acute dermal toxicity: identification of systemic toxic effects and target organs following a single dermal exposure
- Determination of the LD50 value: Quantitative assessment of the potential for acute dermal toxicity
- GHS/CLP classification: Determining the substance’s acute dermal toxicity category and identifying the labelling requirements
- Support for regulatory dossiers: Use in safety assessments of chemicals, pesticides, biocidal products, medicinal products and non-cosmetic products
- Contribution to risk assessment: Provision of baseline data for risk assessment in dermal exposure scenarios
- Selection of the route of exposure: Provision of data on alternative routes of exposure where oral or inhalation testing is not appropriate
Labelling and transport: Data on acute dermal toxicity are used in the classification of chemicals for labelling and transport purposes. Weight of evidence approach: Contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data
OECD TG 402 aims to determine a definitive LD50 value; however, from an animal welfare perspective, dose selection, preliminary tests and criteria for early termination are of crucial importance.
The results should be interpreted in the context of the chemical structure of the substance, other data on acute toxicity, data on local irritation/corrosion, and the exposure assessment.
As part of our nano-testing services, we conduct acute dermal toxicity studies in accordance with OECD TG 402 within our accredited laboratory facilities and under our quality management system, applying scientific rigour. Our scope of services includes the following:
Study design and protocol development
- Preparation of a test report in accordance with OECD TG 402
- Scientific justification of the dosages and conditions of use, based on the physico-chemical properties of the test substance and the available toxicity data
- Selection of a suitable carrier (vehicle) and assessment of solubility and stability
- Determination of species, sex, age, area of application and type of skin covering
- Compliance with ethical approval and animal welfare requirements
- Where appropriate, design of a preliminary trial (range-finding)
Please feel free to contact Nano-Test for information on study design, dose determination, suitability of the carrier, application conditions, sample acceptance criteria, the timetable and reporting procedures for your acute dermal toxicity studies in accordance with OECD TG 402.

